1.
Tangredi C. CO18 | A novel anti-CD138 antibody AT801 to effectively deliver chitosan NBs for targeting of multiple myeloma and reverting tumor microenvironmental invasiveness: <a href="https://haematologica.org/search/search?query=C.+Tangredi">C. Tangredi</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=M.+Argenziano">M. Argenziano</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=D.+Busato">D. Busato</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=S.+Capolla">S. Capolla</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=A.+Zucchetto">A. Zucchetto</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=V.+Gattei">V. Gattei</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=R.+Cavalli">R. Cavalli</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=P.+Macor">P. Macor</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=G.+Toffoli">G. Toffoli</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=M.+Dal+Bo">M. Dal Bo</a><sup>1</sup> | <i><sup>1</sup>Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico di Aviano - CRO, IRCCS; <sup>2</sup>Department of Life Science, University of Trieste; <sup>3</sup>Deparment of drug science and technology, University of Turin; <sup>4</sup>Clinical and Experimental Onco-Hematology, Centro di Riferimento Oncologico di Aviano, IRCCS, Italy.</i&gt;. haematol [Internet]. 2026Mar.3 [cited 2026Mar.4];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.31